Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens

International Journal of Cancer

Volumn 76, Issue 4, 1998, Pages 459-463

  Taylor, Susan L ^a   Platt Higgins, Angela ^a   Rudland, Philip S ^a   Winstanley, John H R ^a   Barraclough, Roger ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; RNA, MESSENGER;

EID: 0031982086     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980518)76:4<459::AID-IJC2>3.0.CO;2-Q     Document Type: Article

References (20)

1. ANANDAPPA, S., WINSTANLEY, J., LEINSTER, S., GREEN, B., RUDLAND, P. and BARRACLOUGH, R., Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Brit. J. Cancer, 69, 772-776 (1994).
2. BERGER, M., LOCHER, G., SAURER, S., GULLICK, W., WATERFIELD, M., GRONER, B. and HYNES, N., Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48, 1238-1243 (1988).
3. BUSMANIS, I., FELEPPA, F., JONES, A., MCGRATH, K., REED, R. and COLLINS, J., Analysis of c-erbB-2 expression using a panel of 6 commercially-available antibodies. Pathology, 26, 261-267 (1995).
4. DE POTTER, C., The neu-oncogene. More than a prognostic indicator. Hum. Pathol., 25, 1264-1268 (1994).
5. DE POTTKR, C., BEGHIN, C., MAKAR, A., VANDERKERCKHOVE, D. and ROELS, H., The neu-oncogene protein as a predictive factor for haematogenous metastasis in breast cancer patients. Int. J. Cancer, 45, 55-58 (1990).
6. DE POTTER, C., QUATACKER, J., MAERTENS, G., VAN DAELE, S., PAUWELS, C., VERHOFSTEDE, C., EECHAUTE, W. and ROELS, H., The subcellular localisation of the neu protein in human normal and neoplastic cells. Int. J. Cancer, 44, 969-974 (1989a).
7. DE POTTER, C., VAN DAELE, S., VAN DE VIJVER, M., PAUWELS, C., MAERTENS, G., DE BOEVER, J., VANDEKERCKHOVE, D. and ROELS, H., The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues. Histopathology, 15, 351-362 (1989b).
8. FIELD, J., SPANDIDOS, D., YIAGNISIS, M., GOSNEY, J., PAPADIMITRIOU, K. and STELL, P., C-erbB-2 expression in squamous-cell carcinoma of the head and neck. Anticancer Res., 12, 613-619 (1992).
9. GRAHAM, R.C. and KARNOVSKY, M.J., The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J. Histochem. Cytochem., 14, 291 (1966).
10. GULLICK, W., BERGER, M., BENNETT, P., ROTHHARD, J. and WATERFIELD, M., Expression of the c-erbB-2 protein in normal and transformed cells. Int. J. Cancer, 40, 246-254 (1987).
11. JOH, J., NOH, D., BAE, C., CHOI, K. and PARK, J., Amplification and over-expression of erbB-2 oncogene in primary human breast tumors. Exp. mol. Med 28, 47-53 (1996).
12. KAY, E., WALSH, C., CASSIDY, M., CURRAN, B. and LEADER, M., C-erbB-2 immunostaining: problems with interpretation. J. clin. Pathol., 47, 816-822 (1994).
13. KOKAI, Y., COHEN, J., DREBIN, J. and GREENE, M., Stage- and tissue-specific expression of the neu oncogene in rat development. Proc. nat. Acad. Sci. (Wash.), 84, 8498-8501 (1987).
14. REIDY, M., TIMM, JR., E. and CARLETON, C., Quantitative RT-PCR for measuring gene expression. Biotechniques, 18, 70-76 (1995).
15. SINGELTON, T., NIEHANS, G., GU, F., LITZ, C., HAGEN, K., QUI, Q., KIANG, D. and STRICKLER, J., Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry. Hum. Pathol., 23, 1141-1150 (1992).
16. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN W.J., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182 (1987).
17. TANNAPFEL, A., KUHN, R., KESSLER, H. and WITTEKIND, C., Expression of c-erbB-2 oncogene product in different tumours and its standardized evaluation. Anal. cell. Pathol., 10, 149-160 (1996).
18. VAN DE VIJVER, M., PETERSE, J., MOOR, W., WISMAN, P., LOMANS, J., DALESIO, O. and NUSSE, R., Neu-protein overexprcssion in breast cancer in association with comedo-type ductal carcinoma in situ and limited prognostgie value in stage 11 breast cancer. N. Engl. J. Med., 319, 1239-1245(1988).
19. VENTER, D., TUZI, N., KUMAR, S. and GULLICK, W., Overexpression of the c-erbB-2 oncopnnein in human breast carcinomas: immunohistological assessment correlatess with gene amplification. Lancet, 2, 69-72 (1987).
20. WINSTANLEY, J., COOKE, T., MURRAY, G.D., PLATT-HIGGINS, S.A., GEORGE, W.D., HOLT, S., MYSKOV, M., SPEDDING, A., BARRACLOUGH, B.R. and RUDLAND, P.S., The long term prognostic significance of c-erbB-2 in primary breast cancer. Brit. J. Cancer. 63, 447-450 (1991).